PMC:7293470 / 2303-2459 JSONTXT

{"project":"LitCovid-PMC-OGER-BB","denotations":[{"id":"T78","span":{"begin":0,"end":20},"obj":"CHEBI:48561;CHEBI:48561"},{"id":"T79","span":{"begin":65,"end":69},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T80","span":{"begin":117,"end":125},"obj":"CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T81","span":{"begin":125,"end":136},"obj":"GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T82","span":{"begin":137,"end":143},"obj":"CHEBI:44811;CHEBI:44811"},{"id":"T83831","span":{"begin":0,"end":20},"obj":"CHEBI:48561;CHEBI:48561"},{"id":"T70978","span":{"begin":65,"end":69},"obj":"CHEBI:23888;CHEBI:23888"},{"id":"T2252","span":{"begin":117,"end":125},"obj":"CL:0000233;GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T56269","span":{"begin":125,"end":136},"obj":"GO:0030168;CHEBI:44811;CHEBI:44811"},{"id":"T88762","span":{"begin":137,"end":143},"obj":"CHEBI:44811;CHEBI:44811"}],"text":"receptor antagonists to block M3 receptors. Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamin"}

{"project":"LitCovid-PD-FMA-UBERON","denotations":[{"id":"T29","span":{"begin":117,"end":125},"obj":"Body_part"}],"attributes":[{"id":"A29","pred":"fma_id","subj":"T29","obj":"http://purl.org/sig/ont/fma/fma62851"}],"text":"receptor antagonists to block M3 receptors. Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamin"}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T46","span":{"begin":126,"end":136},"obj":"http://purl.obolibrary.org/obo/CLO_0001658"}],"text":"receptor antagonists to block M3 receptors. Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamin"}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T27","span":{"begin":9,"end":20},"obj":"Chemical"},{"id":"T28","span":{"begin":30,"end":32},"obj":"Chemical"},{"id":"T30","span":{"begin":65,"end":69},"obj":"Chemical"},{"id":"T31","span":{"begin":117,"end":143},"obj":"Chemical"}],"attributes":[{"id":"A27","pred":"chebi_id","subj":"T27","obj":"http://purl.obolibrary.org/obo/CHEBI_48706"},{"id":"A28","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_51083"},{"id":"A29","pred":"chebi_id","subj":"T28","obj":"http://purl.obolibrary.org/obo/CHEBI_53453"},{"id":"A30","pred":"chebi_id","subj":"T30","obj":"http://purl.obolibrary.org/obo/CHEBI_23888"},{"id":"A31","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_36707"},{"id":"A32","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_44811"},{"id":"A33","pred":"chebi_id","subj":"T31","obj":"http://purl.obolibrary.org/obo/CHEBI_52450"}],"text":"receptor antagonists to block M3 receptors. Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamin"}

{"project":"LitCovid-PD-GO-BP","denotations":[{"id":"T9","span":{"begin":117,"end":136},"obj":"http://purl.obolibrary.org/obo/GO_0030168"}],"text":"receptor antagonists to block M3 receptors. Another bifunctional drug was formulated to antagonize the receptors for platelet-activating factor and histamin"}